CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ·Healthcare·Biotechnology
$2.26
-1.10%
Mkt Cap $1.74M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$5.37 | -$10.15 | -89.01% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$6.63 | -$5.76 | +13.12% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$9.60 | -$6.42 | +33.13% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.10 | -$150.06 | -149960.00% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$3585.43 | -$4033.61 | -12.50% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | — | -$12304.90 | — | — | — |
| Q2 2024 Apr 1, 2024 | — | $6.36K | — | -$57000.00 | -$28511.40 | +49.98% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$51900.00 | -$32413.00 | +37.55% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$84600.00 | -$31212.50 | +63.11% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | — | -$77731.10 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$6000.00 | -$2.23 | +99.96% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$2.40 | -$8104.05 | -337568.75% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$2.40 | -$8104.05 | -337568.75% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$2.40 | -$6303.15 | -262531.25% | — | — |
| Q1 2022 Mar 3, 2022 | — | — | — | -$18909.40 | -$9004.50 | +52.38% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$18909.40 | -$12606.30 | +33.33% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | -$14407.20 | -$13506.80 | +6.25% | — | — |
| Q2 2021 May 14, 2021 | — | — | — | -$3.60 | -$13506.80 | -375088.89% | — | — |
| Q1 2021 Feb 12, 2021 | — | — | — | -$8104.05 | -$16208.10 | -100.00% | — | — |
| Q4 2020 Nov 12, 2020 | — | — | — | -$3.60 | -$10805.40 | -300050.00% | — | — |